Literature DB >> 3965334

Cytochrome P450 of small intestinal epithelial cells. Immunochemical characterization of the increase in cytochrome P450 caused by phenobarbital.

H L Bonkovsky, H P Hauri, U Marti, R Gasser, U A Meyer.   

Abstract

We have studied total cytochrome P450 and the major form of cytochrome P450 increased by phenobarbital in small intestinal epithelial cells and livers of male Sprague-Dawley rats. Using an improved method for preparing microsomes from intestinal epithelial cells, we find that concentrations of total cytochrome P450 in intestinal cell microsomes are 10% of those in liver microsomes, and that this percentage is unchanged after phenobarbital treatment. In untreated rats, less than 5% of total cytochrome P450 of liver or intestinal epithelium is the form induced by phenobarbital, as measured by rocket immunoelectrophoresis. In phenobarbital-treated rats, the major phenobarbital-induced form accounts for approximately 50% of the total in both organs. In the small intestine of phenobarbital-treated rats, the concentrations of total cytochrome P450 and of the major phenobarbital-induced form increase concurrently as epithelial cells mature from crypt to upper villus. Concentrations of total cytochrome P450 and of the major phenobarbital-induced form in the proximal two-thirds of the rat small intestine are twofold higher than in the distal third. Immunoblotting performed with a monoclonal antibody to the major phenobarbital-induced form of cytochrome P450 from rat liver revealed a subtle difference between this form in liver and intestine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3965334     DOI: 10.1016/0016-5085(85)90507-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  22 in total

1.  Enzymatic activities in the microsomes prepared from rat small intestinal epithelial cells by differential procedures.

Authors:  K Mohri; Y Uesawa
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

2.  Effect of intranasal oxygen on hypoxia and tachycardia during endoscopic cholangiopancreatography.

Authors:  S M Griffin; S C Chung; J W Leung; A K Li
Journal:  BMJ       Date:  1990-01-13

3.  Reduced duodenal cytochrome P450 3A protein expression and catalytic activity in patients with cirrhosis.

Authors:  D J McConn; Y S Lin; T L Mathisen; D K Blough; Y Xu; T Hashizume; S L Taylor; K E Thummel; M C Shuhart
Journal:  Clin Pharmacol Ther       Date:  2009-02-11       Impact factor: 6.875

4.  Effects of furanocoumarin derivatives in grapefruit juice on nifedipine pharmacokinetics in rats.

Authors:  K Mohri; Y Uesawa
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

5.  Drug-metabolizing enzyme activities in the liver and intestine of rats exposed to DDT: effects of vitamin A status.

Authors:  I de Waziers; V Azaïs
Journal:  Arch Environ Contam Toxicol       Date:  1987-05       Impact factor: 2.804

6.  The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450.

Authors:  G I Murray; T S Barnes; H F Sewell; S W Ewen; W T Melvin; M D Burke
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

7.  Drug metabolism in rat colon: resolution of enzymatic constituents and characterization of activity.

Authors:  R J Oshinsky; H W Strobel
Journal:  Mol Cell Biochem       Date:  1987-05       Impact factor: 3.396

8.  Demonstration by in situ hybridization of the zonal modulation of rat liver cytochrome P-450b and P-450e gene expression after phenobarbital.

Authors:  E Wojcik; C Dvorak; J Chianale; P G Traber; D Keren; J J Gumucio
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

9.  Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man.

Authors:  P B Watkins; S A Wrighton; E G Schuetz; D T Molowa; P S Guzelian
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

10.  Differential effect of acute hepatic failure on in vivo and in vitro P-glycoprotein functions in the intestine.

Authors:  Ryoko Yumoto; Teruo Murakami; Mikihisa Takano
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.